Further studies that are able to integrate other biomarkers known to play a role in the physiopathology of AD (tau, inflammation, etc.)within a longitudinal design would be useful to unravel their relative roles, sequence, and causal relationships in the context of DS. The gene discussed is MAPT; the disease is Dravet syndrome.